SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Burton Michael G

(Last) (First) (Middle)
C/O CENVEO, INC.
200 FIRST STAMFORD PLACE

(Street)
STAMFORD CT 06902

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
02/20/2014
3. Issuer Name and Ticker or Trading Symbol
CENVEO, INC [ CVO ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President, Labels, Pkg & Print
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 482,306 D(1)(2)(3)
Common Stock 1,000 I By Wife
Common Stock 11,500 I By Daughter
Common Stock 1,275 I By Daughter
Common Stock 24,975 I By Son
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) (4) 06/08/2015 Common Stock 17,500 $4.9 D
Employee Stock Option (right to buy) (5) 07/01/2015 Common Stock 40,000 $4.22 D
Employee Stock Option (right to buy) (6) 05/21/2016 Common Stock 20,000 $7.02 D
Employee Stock Option (right to buy) (7) 01/12/2017 Common Stock 20,000 $5.62 D
Employee Stock Option (right to buy) (8) 05/01/2019 Common Stock 15,000 $2 D
Explanation of Responses:
1. Includes 64,550 shares purchased under Issuer's Employee Stock Purchase Plan and 19,175 shares purchased under Issuer's 401(k) Plan.
2. Includes Restricted Share Unit Awards as follows: 3 awards outstanding as follows: 5/21/2010 for 10,000 shares; 1/12/2011 for 15,000 shares; and 5/1/2013 award for 25,000 shares.
3. Includes Performance Share Unit Award dated 5/1/2013 for 40,000 shares that will vest 100% on May 1, 2014 upon achievement of performance targets.
4. This option is exercisable in 4 equal annual installments. The first installment became exercisable on June 8, 2010 and subsequent installments each year thereafter.
5. This option is exercisable in 4 equal annual installments. The first installment became exercisable on July 1, 2010 and subsequent installments each year thereafter.
6. This option is exercisable in 4 equal annual installments. The first installment became exercisable on May 21, 2011 and subsequent installments each year thereafter.
7. This option is exercisable in 4 equal annual installments. The first installment became exercisable on January 12, 2012 and subsequent installments each year thereafter.
8. This option is exercisable in 4 equal annual installments. The first installment will become exercisable on May 1, 2014 and subsequent installments each year thereafter.
Remarks:
Exhibit 24 - Confirming Statement
Michael G. Burton 03/03/2014
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.